Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 233-118-8 | CAS number: 10039-54-0
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Description of key information
Skin sensitization:
GPMT: sensitizing
Skin paining test: sensitizing
MEST: sensitizing (additional tests: not sensitizing)
Patch test (human): sensitizing
Respiratory sensitization:
Guinea pig maximisation test with an inhalation aerosol or intratracheal challenge: not respiratory sensitizing
Key value for chemical safety assessment
Skin sensitisation
Link to relevant study records
- Endpoint:
- skin sensitisation: in vivo (non-LLNA)
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- other: Acceptable, well documented publication (with a short method description) which meets basic scientific principles.
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 406 (Skin Sensitisation)
- Deviations:
- not applicable
- Remarks:
- (due to missing details in the method description)
- GLP compliance:
- not specified
- Type of study:
- guinea pig maximisation test
- Justification for non-LLNA method:
- Study was performed prior to existence of LLNA guideline.
- Species:
- guinea pig
- Strain:
- Hartley
- Sex:
- not specified
- Details on test animals and environmental conditions:
- TEST ANIMALS
- Acclimation period: 14 days - Route:
- intradermal and epicutaneous
- Vehicle:
- water
- Concentration / amount:
- - intradermal injection: 5%; - topical induction: 25%
- Route:
- epicutaneous, occlusive
- Vehicle:
- water
- Concentration / amount:
- - challenge: 10%
- No. of animals per dose:
- 15 (test group), 6 (control group)
- Details on study design:
- MAIN STUDY
A. INDUCTION EXPOSURE
- Exposure period: 48 h
- Site: intradermal injected skin site
B. CHALLENGE EXPOSURE
- Exposure period: 24 h
- Site: naive skin site
- Group:
- test chemical
- No. with + reactions:
- 15
- Total no. in group:
- 15
- Remarks on result:
- positive indication of skin sensitisation
Reference
100% of the treated guinea pigs showed a positive reaction. Based on a self-made ranking and classification system (Gad,1988), hydroxylamine sulfate has to be classified in class III (moderate sensitizer).
Endpoint conclusion
- Endpoint conclusion:
- adverse effect observed (sensitising)
- Additional information:
Several studies are available regarding the skin sensitization potential of bis-(hydroxylammonium) sulphate.
An in vivo study with 15 guinea pigs in the test group and 6 guinea pigs as control group was conducted, according to the method described by Magnusson and Kligman. Intradermal injection was conducted with the test material (5 %) in water, FCA and the test material 5 % in FCA. Epicutaneous induction (one week after intradermal induction) was conducted with 25 % of the test material in water. The challenge (14 days after epicutaneous induction) was performed with 10 % of the test material in water. 100% of the treated guinea pigs showed a positive reaction, therefore the test result was considered as positive.
A Buehler test with 20 guinea pigs in the treatment group (an equal number of previously untreated animals was challenged as a control and a third group (unknown number of animals) was carried through the entire test as a vehicle control). The test compound (0.2 % in surfactant solution) was applied to the skin for a 6 h treatment period once each week for 3 successive weeks. This induction series was followed in 2 weeks by dual 6 h challenge patches on the depilated flanks of each animal (test substance concentration: 0.2% in surfactant solution). 0/20 treated animals showed a positive result.
In a non-guideline skin paining test, test substance (40 % in water) was applied to one side of the flanks of 10 guinea pigs. This procedure was repeated daily until irritation was clearly observed. 12 days after the last induction procedure the other flank of the animals was treated with 4 % aqueous hydroxylammonium sulphate solution. At this site 8/10 animals showed irritation, edema and little nodules demonstrating a sensitizing effect.
In a mouse ear swelling test, mice (10-15 animals) received two i.d. injections (overall 0.05 ml) FCA into the stomach region prior to the first induction treatment. Then, the animals were topically dosed at the stomach site with 10 % hydroxylammmonium sulphate in 25 % ethanol at three consecutive days. After a rest period of 7 days 10 % of the test compound in 25 % ethanol was applied to the right ear. The control group consisted of 5 – 10 mice. A total of 72 compounds were tested. 33 % of the mice treated with hydroxylammonium sulphate showed a positive reaction. The identical test procedure (mouse ear swelling test) described was used by two other laboratories. However, both laboratories reported negative results with hydroxylammonium sulphate.
Additional tests support the assessment of the test substance as sensitizing, however, only abstracts are available for these studies.
Data of human subjects support the sensitizing property of hydroxylammonium sulphate. Hydroxylammonium sulphate sensitized 3 of 76 (4 %) human subjects in an epicutaneous patch test. The patches were left on the dorsal skin of the upper arm for 24 h and were applied 3 days per week for 3 weeks. At the beginning of the 6th week, each subject is challenged with the test material at the same sites as used for induction and at fresh sites on the opposite arm. The challenge patches are removed after 24 h. There are also two case reports of limited validity which also describe a sensitizing potential of hydroxylammonium sulphate.
Respiratory sensitisation
Endpoint conclusion
- Additional information:
Respiratory sensitization:
One report concerning respiratory sensitization of bis(hydroxylammonium) sulphate is available (cited in the EU Risk Assessment Report of bis(hydroxylammonium)sulphate). Guinea pigs that have been subjected to a Magnusson Kligman Test with bis(hydroxylammonium) sulphate were subsequently treated as follows: 2 groups of 4 animals inhaled an aerosol (0.0065 mg/l and 0.0132 mg/l, respectively) for 30 min. Four other groups of guinea pigs (4/group) were treated via the intratracheal route (5, 15, 25 and 75 mg/kg bw). Based on measured changes in breathing rates from base line levels the substance did not produce any indication of pulmonary sensitization (an increase in breathing rates was considered a sign of pulmonary sensitization and a decrease in breathing rate a sign of sensory irritation).
Additionally, a case report on occupational asthma in two workers of the paper recycling industry is available. The authors correlate the onset of asthma with the introduction of hydroxylamine into the de-inking process and the subsequent exposure of both workers. However, the exposure is not described, confounding factors are not sufficiently addressed and the question whether other chemicals used in the process might be the cause of the symptoms is not addressed at all. Exposures to possible respiratory sensitizers in the non-work environment has not been excluded and no information is given on whether this was monitored during the described "occupational challenge" of Mr. Y. Therefore, the information reported cannot be used for assessment.
Justification for classification or non-classification
Skin sensitization:
Based on the data available and in accordance with the criteria laid down in Regulation EC 1272/2008 (CLP), classification for skin sensitizing properties is warranted. In accordance with the listing in Annex VI of Regulation 1272/2008, the substance is classified as H317 ("May cause an allergic skin reaction").
Respiratory sensitization:
Based on the data available and in accordance with the criteria laid down in Regulation EC 1272/2008 (CLP), conclusive human evidence or indicative animal studies must be available to assess the potential of a substance to cause respiratory sensitization. In this case, indicative animal data suggest the substance be a non-sensitizer and a poorly reported case study does not provide conclusive evidence to the contrary. Therefore, non-classification for respiratory sensitization is warranted.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.